Description and Brand Names

Drug information provided by: Micromedex

US Brand Name

  1. Bexxar

Descriptions


Tositumomab and iodine I 131 tositumomab combination regimen is used to treat patients with CD20-positive, relapsed or refractory non-Hodgkin's lymphoma. It is also given to patients with non-Hodgkin's lymphoma who already have received rituximab.

This medicine is to be given only by or under the immediate supervision of your doctor.

The tositumomab and iodine I 131 tositumomab combination regimen will be withdrawn from the United States market on February 20, 2014.

This product is available in the following dosage forms:

  • Solution